| Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater A Nemudryi*, A Nemudraia*, T Wiegand, K Surya, M Buyukyoruk, C Cicha, ... Cell Reports Medicine 1 (6), *Co-first authors, 2020 | 543 | 2020 |
| SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression A Nemudryi*, A Nemudraia*, T Wiegand, J Nichols, DT Snyder, ... Cell reports 35 (9), *Co-first authors, 2021 | 78 | 2021 |
| Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic A Santiago-Frangos, LN Hall, A Nemudraia, A Nemudryi, P Krishna, ... Cell Reports Medicine 2 (6), 2021 | 65* | 2021 |
| Phage peptide libraries as a source of targeted ligands AA Nemudraya, VA Richter, EV Kuligina Acta Naturae (англоязычная версия) 8 (1 (28)), 48-57, 2016 | 34 | 2016 |
| The rise and fall of SARS-CoV-2 variants and ongoing diversification of omicron T Wiegand, A Nemudryi, A Nemudraia, A McVey, A Little, DN Taylor, ... Viruses 14 (9), 2009, 2022 | 27* | 2022 |
| Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnostic A Nemudraia, A Nemudryi, M Buyukyoruk, AM Scherffius, T Zahl, ... Nature Communications 13 (1), 7762, 2022 | 14 | 2022 |
| CRISPR-Cas, Argonaute proteins and the emerging landscape of amplification-free diagnostics A Santiago-Frangos, A Nemudryi, A Nemudraia, T Wiegand, JE Nichols, ... Methods 205, 1-10, 2022 | 14 | 2022 |
| Tumor-specific peptide, selected from a phage peptide library, enhances antitumor activity of lactaptin AA Nemudraya, AA Makartsova, AS Fomin, AA Nushtaeva, OA Koval, ... PLoS One 11 (8), e0160980, 2016 | 14 | 2016 |
| Selection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptin AA Nemudraya, EV Kuligina, AA Ilyichev, AS Fomin, GA Stepanov, ... Oncology Letters 12 (6), 4547-4555, 2016 | 11 | 2016 |
| Europe PMC free article A Nemudryi, A Nemudraia, K Surya, T Wiegand, M Buyukyoruk, ... CrossRef][Google Scholar], 2020 | 10 | 2020 |
| Analysis of the efficiency of recombinant Escherichia coli strain cultivation in a gas‐vortex bioreactor AV Savelyeva, AA Nemudraya, VF Podgornyi, NV Laburkina, ... Biotechnology and Applied Biochemistry 64 (5), 712-718, 2017 | 10 | 2017 |
| Severe acute respiratory syndrome coronavirus 2 is detected in the gastrointestinal tract of asymptomatic endoscopy patients but is unlikely to pose a significant risk to … MD Cherne, AB Gentry, A Nemudraia, A Nemudryi, JF Hedges, H Walk, ... Gastro Hep Advances 1 (5), 844-852, 2022 | 5* | 2022 |
| CRISPR-based engineering of RNA viruses A Nemudryi, A Nemudraia, JE Nichols, AM Scherffius, T Zahl, ... Science Advances 9 (37), eadj8277, 2023 | 2 | 2023 |
| The diverse evolutionary histories of domesticated metaviral capsid genes in mammals WS Henriques, JM Young, A Nemudryi, A Nemudraia, B Wiedenheft, ... Molecular Biology and Evolution 41 (4), msae061, 2024 | 1 | 2024 |
| Engineered crispr-cas systems and methods for sensitive and specific diagnostics BA Wiedenheft, A Santiago-frangos, AA Nemudraia, AA Nemudryi US Patent App. 17/240,858, 2021 | 1 | 2021 |
| Repair of CRISPR-guided RNA breaks enables site-specific RNA excision in human cells A Nemudraia, A Nemudryi, B Wiedenheft Science, eadk5518, 2024 | | 2024 |
| Nucleic acid detection using type III CRISPR complex BA Wiedenheft, A Santiago-frangos, AA Nemudraia, AA Nemudryi US Patent 11,814,689, 2023 | | 2023 |
| Programmable delivery of rna-guided crispr-cas proteins to subcellular organelles BA Wiedenheft, AA Nemudraia, AA Nemudryi US Patent App. 18/299,692, 2023 | | 2023 |
| Engineered crispr-cas systems and methods for sensitive and specific diagnostics BA Wiedenheft, A Santiago-frangos, AA Nemudraia, AA Nemudryi US Patent App. 17/814,674, 2023 | | 2023 |
| Crispr-based programmable rna editing BA Wiedenheft, JE Nichols, AA Nemudraia, AA Nemudryi US Patent App. 17/811,391, 2023 | | 2023 |
Artem NemudryiMontana State UniversityVerified email at montana.edu
